Table of Contents Global Neurotherapeutic Drugs Market Professional Survey Report 2017 1 Industry Overview of Neurotherapeutic Drugs 1.1 Definition and Specifications of Neurotherapeutic Drugs 1.1.1 Definition of Neurotherapeutic Drugs 1.1.2 Specifications of Neurotherapeutic Drugs 1.2 Classification of Neurotherapeutic Drugs 1.2.1 Global Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) 1.2.2 Global Neurotherapeutic Drugs Production Market Share (%) by Types in 2017 1.2.3 Peripheral Nervous System Disorders (PNS) Disorder 1.2.4 Autonomous Nervous System (ANS) Disorder 1.2.5 Central Nervous System (CNS) Disorders 1.2.6 Other 1.3 Applications of Neurotherapeutic Drugs 1.3.1 Global Neurotherapeutic Drugs Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Hosptical 1.3.3 Drug Stores 1.3.4 Other 1.4 Global Neurotherapeutic DrugsMarket by Regions (2012-2023) 1.4.1 Global Neurotherapeutic Drugs Market Size and Growth Rate (%) Comparison by Regions (2012-2023) 1.4.2 North AmericaNeurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.3 EuropeNeurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.4 ChinaNeurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.5 JapanNeurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.6 Southeast AsiaNeurotherapeutic Drugs Status and Prospect (2012-2023) 1.5 Global Neurotherapeutic Drugs Market Size (2012-2023) 1.5.1 Global Neurotherapeutic Drugs Revenue (Million USD) Status and Outlook (2012-2023) 1.5.2 Global Neurotherapeutic Drugs Capacity, Production (K Units) Status and Outlook (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Neurotherapeutic Drugs 2.2 Raw Material Analysis of Neurotherapeutic Drugs 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Neurotherapeutic Drugs 2.4 Other Costs Analysis of Neurotherapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs 2.6 Manufacturing Process Analysis of Neurotherapeutic Drugs 2.7 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 2.8 Downstream Buyers of Neurotherapeutic Drugs 3 Global Neurotherapeutic Drugs Manufacturers Profiles/Analysis 3.1 Abbott 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.1.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.1.2.2 Autonomous Nervous System (ANS) Disorder 3.1.2.3 Central Nervous System (CNS) Disorders 3.1.3 Abbott 2017 Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.1.4 Abbott 2017 Business Region Distribution Analysis 3.1.5 Abbott Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.2 BD 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.2.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.2.2.2 Autonomous Nervous System (ANS) Disorder 3.2.2.3 Central Nervous System (CNS) Disorders 3.2.3 BD 2017 Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.2.4 BD 2017 Business Region Distribution Analysis 3.2.5 BD Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis AG 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.3.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.3.2.2 Autonomous Nervous System (ANS) Disorder 3.3.2.3 Central Nervous System (CNS) Disorders 3.3.3 Novartis AG 2017 Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.3.4 Novartis AG 2017 Business Region Distribution Analysis 3.3.5 Novartis AG Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Johnson & Johnson 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.4.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.4.2.2 Autonomous Nervous System (ANS) Disorder 3.4.2.3 Central Nervous System (CNS) Disorders 3.4.3 Johnson & Johnson 2017 Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.4.4 Johnson & Johnson 2017 Business Region Distribution Analysis 3.4.5 Johnson & Johnson Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Pfizer 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.5.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.5.2.2 Autonomous Nervous System (ANS) Disorder 3.5.2.3 Central Nervous System (CNS) Disorders 3.5.3 Pfizer 2017 Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.5.4 Pfizer 2017 Business Region Distribution Analysis 3.5.5 Pfizer Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Sanofi-Aventis 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.6.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.6.2.2 Autonomous Nervous System (ANS) Disorder 3.6.2.3 Central Nervous System (CNS) Disorders 3.6.3 Sanofi-Aventis Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.6.4 Sanofi-Aventis 2017 Business Region Distribution Analysis 3.6.5 Sanofi-Aventis Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Biogen 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.7.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.7.2.2 Autonomous Nervous System (ANS) Disorder 3.7.2.3 Central Nervous System (CNS) Disorders 3.7.3 Biogen 2017 Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.7.4 Biogen 2017 Business Region Distribution Analysis 3.7.5 Biogen Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.8.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.8.2.2 Autonomous Nervous System (ANS) Disorder 3.8.2.3 Central Nervous System (CNS) Disorders 3.8.3 GlaxoSmithKline 2017 Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.8.4 GlaxoSmithKline 2017 Business Region Distribution Analysis 3.8.5 GlaxoSmithKline Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.9 AstraZeneca Merck 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.9.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.9.2.2 Autonomous Nervous System (ANS) Disorder 3.9.2.3 Central Nervous System (CNS) Disorders 3.9.3 AstraZeneca Merck 2017 Neurotherapeutic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.9.4 AstraZeneca Merck 2017 Business Region Distribution Analysis 3.9.5 AstraZeneca Merck Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.10.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.10.2.2 Autonomous Nervous System (ANS) Disorder 3.10.2.3 Central Nervous System (CNS) Disorders 4 Technical Data and Manufacturing Plants Analysis of Neurotherapeutic Drugs 4.1 Capacity and Commercial Production Date of Global Neurotherapeutic Drugs Major Manufacturers in 2017 4.2 Manufacturing Plants Distribution of Global Neurotherapeutic Drugs Major Manufacturers in 2017 4.4 R&D Status and Technology Source of Global Neurotherapeutic Drugs Major Manufacturers in 2017 4.4 Raw Materials Sources Analysis of Global Neurotherapeutic Drugs Major Manufacturers in 2017 5 Global Neurotherapeutic Drugs Overall Market Overview 5.1 2012-2017 Overall Market Analysis 5.2 Capacity Analysis 5.2.1 2012-2017 Global Neurotherapeutic Drugs Capacity and Growth Rate Analysis 5.2.2 2017 Neurotherapeutic Drugs Capacity Analysis (Company Segment) 5.3 Sales Analysis 5.3.1 2012-2017 Global Neurotherapeutic Drugs Sales and Growth Rate Analysis 5.3.2 2017 Neurotherapeutic Drugs Sales Analysis (Company Segment) 5.4 Sales Price Analysis 5.4.1 2012-2017 Global Neurotherapeutic Drugs Sales Price 5.4.2 2017 Neurotherapeutic Drugs Sales Price Analysis (Company Segment) 6 Neurotherapeutic Drugs Regional Market Analysis 6.1 North America Neurotherapeutic Drugs Market Analysis 6.1.1 North America Neurotherapeutic Drugs Market Overview 6.1.2 North America 2012-2017 Neurotherapeutic Drugs Local Supply, Import, Export, Local Consumption Analysis 6.1.3 North America 2012-2017 Neurotherapeutic Drugs Sales Price Analysis 6.1.4 North America 2017 Neurotherapeutic Drugs Market Share Analysis 6.2 Europe Neurotherapeutic Drugs Market Analysis 6.2.1 Europe Neurotherapeutic Drugs Market Overview 6.2.2 Europe 2012-2017 Neurotherapeutic Drugs Local Supply, Import, Export, Local Consumption Analysis 6.2.3 Europe 2012-2017 Neurotherapeutic Drugs Sales Price Analysis 6.2.4 Europe 2017 Neurotherapeutic Drugs Market Share Analysis 6.3 China Neurotherapeutic Drugs Market Analysis 6.3.1 China Neurotherapeutic Drugs Market Overview 6.3.2 China 2012-2017 Neurotherapeutic Drugs Local Supply, Import, Export, Local Consumption Analysis 6.3.3 China 2012-2017 Neurotherapeutic Drugs Sales Price Analysis 6.3.4 China 2017 Neurotherapeutic Drugs Market Share Analysis 6.4 Japan Neurotherapeutic Drugs Market Analysis 6.4.1 Japan Neurotherapeutic Drugs Market Overview 6.4.2 Japan 2012-2017 Neurotherapeutic Drugs Local Supply, Import, Export, Local Consumption Analysis 6.4.3 Japan 2012-2017 Neurotherapeutic Drugs Sales Price Analysis 6.4.4 Japan 2017 Neurotherapeutic Drugs Market Share Analysis 6.5 Southeast Asia Neurotherapeutic Drugs Market Analysis 6.5.1 Southeast Asia Neurotherapeutic Drugs Market Overview 6.5.2 Southeast Asia 2012-2017 Neurotherapeutic Drugs Local Supply, Import, Export, Local Consumption Analysis 6.5.3 Southeast Asia 2012-2017 Neurotherapeutic Drugs Sales Price Analysis 6.5.4 Southeast Asia 2017 Neurotherapeutic Drugs Market Share Analysis 6.6 India Neurotherapeutic Drugs Market Analysis 6.6.1 India Neurotherapeutic Drugs Market Overview 6.6.2 India 2012-2017 Neurotherapeutic Drugs Local Supply, Import, Export, Local Consumption Analysis 6.6.3 India 2012-2017 Neurotherapeutic Drugs Sales Price Analysis 6.6.4 India 2017 Neurotherapeutic Drugs Market Share Analysis 7 Global 2012-2017 Neurotherapeutic Drugs Segment Market Analysis (by Type) 7.1 Global 2012-2017 Neurotherapeutic Drugs Sales by Type 7.2 Different Types of Neurotherapeutic Drugs Product Interview Price Analysis 7.3 Different Types of Neurotherapeutic Drugs Product Driving Factors Analysis 7.3.1 Peripheral Nervous System Disorders (PNS) Disorder of Neurotherapeutic Drugs Growth Driving Factor Analysis 7.3.2 Autonomous Nervous System (ANS) Disorder of Neurotherapeutic Drugs Growth Driving Factor Analysis 7.3.3 Central Nervous System (CNS) Disorders of Neurotherapeutic Drugs Growth Driving Factor Analysis 7.3.4 Other of Neurotherapeutic Drugs Growth Driving Factor Analysis 8 Global 2012-2017 Neurotherapeutic Drugs Segment Market Analysis (by Application) 8.1 Global 2012-2017 Neurotherapeutic Drugs Consumption by Application 8.2 Different Application of Neurotherapeutic Drugs Product Interview Price Analysis 8.3 Different Application of Neurotherapeutic Drugs Product Driving Factors Analysis 8.3.1 Hosptical of Neurotherapeutic Drugs Growth Driving Factor Analysis 8.3.2 Drug Stores of Neurotherapeutic Drugs Growth Driving Factor Analysis 8.3.3 Other of Neurotherapeutic Drugs Growth Driving Factor Analysis 9 Development Trend of Analysis of Neurotherapeutic Drugs Market 9.1 Global Neurotherapeutic Drugs Market Trend Analysis 9.1.1 Global 2018-2023 Neurotherapeutic Drugs Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2023 Neurotherapeutic Drugs Sales Price Forecast 9.2 Neurotherapeutic Drugs Regional Market Trend 9.2.1 North America 2018-2023 Neurotherapeutic Drugs Consumption Forecast 9.2.2 Europe 2018-2023 Neurotherapeutic Drugs Consumption Forecast 9.2.3 China 2018-2023 Neurotherapeutic Drugs Consumption Forecast 9.2.4 Japan 2018-2023 Neurotherapeutic Drugs Consumption Forecast 9.2.5 Southeast Asia 2018-2023 Neurotherapeutic Drugs Consumption Forecast 9.2.6 India 2018-2023 Neurotherapeutic Drugs Consumption Forecast 9.3 Neurotherapeutic Drugs Market Trend (Product Type) 9.4 Neurotherapeutic Drugs Market Trend (Application) 10 Marketing Strategy Analysis, Distributors/Traders 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List 11 Neurotherapeutic Drugs Marketing Type Analysis 11.1 Neurotherapeutic Drugs Regional Marketing Type Analysis 11.2 Neurotherapeutic Drugs International Trade Type Analysis 11.3 Traders or Distributors with Contact Information of Neurotherapeutic Drugs by Region 11.4 Neurotherapeutic Drugs Supply Chain Analysis 12 Consumers Analysis of Neurotherapeutic Drugs 12.1 Consumer 1 Analysis 12.2 Consumer 2 Analysis 12.3 Consumer 3 Analysis 12.4 Consumer 4 Analysis 13 Conclusion of the Global Neurotherapeutic Drugs Market Professional Survey Report 2018 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Market Size (Million USD) Status and Outlook 2012-2023 Table Global Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) Table Global Neurotherapeutic Drugs Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Global Neurotherapeutic Drugs Consumption (K Units) by Application (2016-2023) Figure Picture of Neurotherapeutic Drugs Table Product Specifications of Neurotherapeutic Drugs Table Global Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Global Neurotherapeutic Drugs Production Market Share (%) by Types in 2017 Figure Peripheral Nervous System Disorders (PNS) Disorder Picture Table Major Manufacturers of Peripheral Nervous System Disorders (PNS) Disorder Figure Autonomous Nervous System (ANS) Disorder Picture Table Major Manufacturers of Autonomous Nervous System (ANS) Disorder Figure Central Nervous System (CNS) Disorders Picture Table Major Manufacturers of Central Nervous System (CNS) Disorders Table Global Neurotherapeutic Drugs Consumption (K Units) Comparison by Applications (2012-2023) Figure Global Neurotherapeutic Drugs Consumption (K Units) Market Share (%) by Applications in 2017 Figure Hosptical Picture Figure Drug Stores Picture Figure Other Picture Table Global Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) Figure North America Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure India Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Global Neurotherapeutic Drugs Revenue (Million USD) Status and Outlook (2012-2023) Figure Global Neurotherapeutic Drugs Capacity, Production (K Units) Status and Outlook (2012-2023) Figure Industry Chain Structure of Neurotherapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Neurotherapeutic Drugs Table Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Neurotherapeutic Drugs Table Abbott Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table Central Nervous System (CNS) Disorders Neurotherapeutic Drugs Overview Table 2017 Abbott Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 Abbott Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Other and Its Application Share Table BD Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table Central Nervous System (CNS) Disorders Neurotherapeutic Drugs Overview Table 2017 BD Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 BD Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table BD Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table BD Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table BD Neurotherapeutic Drugs Volume in Other and Its Application Share Table Novartis AG Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table 2017 Novartis AG Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 Novartis AG Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis AG Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Other and Its Application Share Table Johnson & Johnson Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table Central Nervous System (CNS) Disorders Neurotherapeutic Drugs Overview Table 2017 Johnson & Johnson Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 Johnson & Johnson Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Other and Its Application Share Table Pfizer Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table 2017 Pfizer Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 Pfizer Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Other and Its Application Share Table Sanofi-Aventis Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table 2017 Sanofi-Aventis Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 Sanofi-Aventis Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Other and Its Application Share Table Biogen Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table 2017 Biogen Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 Biogen Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biogen Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Other and Its Application Share Table GlaxoSmithKline Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table 2017 GlaxoSmithKline Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 GlaxoSmithKline Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Other and Its Application Share Table AstraZeneca Merck Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table 2017 AstraZeneca Merck Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 AstraZeneca Merck Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Other and Its Application Share Table Information List Table Peripheral Nervous System Disorders (PNS) Disorder Neurotherapeutic Drugs Overview Table Autonomous Nervous System (ANS) Disorder Neurotherapeutic Drugs Overview Table 2017 Neurotherapeutic Drugs Revenue, Sales, Ex-factory Price Figure 2017 Neurotherapeutic Drugs Business Region Distribution Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Neurotherapeutic Drugs Volume in Other and Its Application Share Table Capacity (K Units) and Commercial Production Date of Global Neurotherapeutic Drugs Major Manufacturers in 2017 Table Manufacturing Plants Distribution of Global Neurotherapeutic Drugs Major Manufacturers in 2017 Table R&D Status and Technology Source of Global Neurotherapeutic Drugs Major Manufacturers in 2017 Table Raw Materials Sources Analysis of Global Neurotherapeutic Drugs Major Manufacturers in 2017 Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Neurotherapeutic Drugs 2012-2017 Figure Global 2012-2017 Neurotherapeutic Drugs Sales (K Units) and Growth Rate Figure Global 2012-2017 Neurotherapeutic Drugs Market Size (Million USD) and Growth Rate Figure 2012-2017 Global Neurotherapeutic Drugs Capacity and Growth Rate Table 2017 Global Neurotherapeutic Drugs Capacity List (Company Segment) Figure 2012-2017 Global Neurotherapeutic Drugs Sales and Growth Rate Table 2017 Global Neurotherapeutic Drugs Sales List (Company Segment) Figure 2012-2017 Global Neurotherapeutic Drugs Sales Price Table 2017 Global Neurotherapeutic Drugs Sales Price List (Company Segment) Figure North America Capacity Overview Figure North America 2017 Neurotherapeutic Drugs Capacity Market Share Table North America Supply, Import, Export and Consumption of Neurotherapeutic Drugs 2012-2017 (K Units) Figure North America 2012-2017 Neurotherapeutic Drugs Sales Price (USD/Unit) Figure North America 2017 Neurotherapeutic Drugs Sales Market Share Figure Europe Capacity Overview Figure Europe 2017 Neurotherapeutic Drugs Capacity Market Share Table Europe Supply, Import, Export and Consumption of Neurotherapeutic Drugs 2012-2017 (K Units) Figure Europe 2012-2017 Neurotherapeutic Drugs Sales Price (USD/Unit) Figure North America 2017 Neurotherapeutic Drugs Sales Market Share Figure China Capacity Overview Figure China 2017 Neurotherapeutic Drugs Capacity Market Share Table China Supply, Import, Export and Consumption of Neurotherapeutic Drugs 2012-2017 (K Units) Figure China 2012-2017 Neurotherapeutic Drugs Sales Price (USD/Unit) Figure China 2017 Neurotherapeutic Drugs Sales Market Share Figure Japan Capacity Overview Figure Japan 2017 Neurotherapeutic Drugs Capacity Market Share Table Japan Supply, Import, Export and Consumption of Neurotherapeutic Drugs 2012-2017 (K Units) Figure Japan 2012-2017 Neurotherapeutic Drugs Sales Price (USD/Unit) Figure Japan 2017 Neurotherapeutic Drugs Sales Market Share Figure Southeast Asia Capacity Overview Figure Southeast Asia 2017 Neurotherapeutic Drugs Capacity Market Share Table Southeast Asia Supply, Import, Export and Consumption of Neurotherapeutic Drugs 2012-2017 (K Units) Figure Southeast Asia 2012-2017 Neurotherapeutic Drugs Sales Price (USD/Unit) Figure Southeast Asia 2017 Neurotherapeutic Drugs Sales Market Share Figure India Capacity Overview Figure India 2017 Neurotherapeutic Drugs Capacity Market Share Table India Supply, Import, Export and Consumption of Neurotherapeutic Drugs 2012-2017 (K Units) Figure India 2012-2017 Neurotherapeutic Drugs Sales Price (USD/Unit) Figure India 2017 Neurotherapeutic Drugs Sales Market Share Table Global 2012-2017 Neurotherapeutic Drugs Sales by Type Table Different Types Neurotherapeutic Drugs Product Interview Price Table Global 2012-2017 Neurotherapeutic Drugs Sales by Application Table Different Application Neurotherapeutic Drugs Product Interview Price Figure Global 2018-2023 Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast Figure Global 2018-2023 Neurotherapeutic Drugs Market Size (Million USD) and Growth Rate Forecast Figure Global 2018-2023 Neurotherapeutic Drugs Sales Price (USD/Unit) Forecast Figure North America 2018-2023 Neurotherapeutic Drugs Consumption Volume and Growth Rate Forecast Figure Europe 2018-2023 Neurotherapeutic Drugs Consumption Volume and Growth Rate Forecast Figure China 2018-2023 Neurotherapeutic Drugs Consumption Volume and Growth Rate Forecast Figure Japan 2018-2023 Neurotherapeutic Drugs Consumption Volume and Growth Rate Forecast Figure Southeast Asia 2018-2023 Neurotherapeutic Drugs Consumption Volume and Growth Rate Forecast Figure India 2018-2023 Neurotherapeutic Drugs Consumption Volume and Growth Rate Forecast Table Global Sales Volume (K Units) of Neurotherapeutic Drugs by Autonomous Nervous System (ANS) Disorder2018-2023 Table Global Consumption Volume (K Units) of Neurotherapeutic Drugs by Drug Stores2018-2023 Table Distributors/Traders List Table Traders or Distributors with Contact Information of Neurotherapeutic Drugs by Regions Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott BD Novartis AG Johnson & Johnson Pfizer Sanofi-Aventis Biogen GlaxoSmithKline AstraZeneca Merck